KKI 7

Product Code:

TAR-T32399

Product Group:

Inhibitors and Activators

Supplier:

TargetMol

Regulatory Status:

RUO

Shipping:

cool pack

Storage:

-20°C

No additional charges, what you see is what you pay! *

Code	Size	Price

TAR-T32399-100mg

100mg

Enquire

Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.

Quantity:

TAR-T32399-500mg

500mg

Enquire

Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.

Quantity:

Prices exclude any Taxes / VAT

How to order with us Contact us

Further Information

Bioactivity:

KKI 7 is a peptide analog.

CAS:

113584-01-3

Molecular Weight:

758.91

Purity:

0.98

SMILES:

[C@H](CC1=CC=CC=C1)(C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CCC(N)=O)C(N)=O)=O)C(C)C)=O)CO)=O)CCCNC(=N)N)=O)NC(CC2CCCCC2)=O

Documents

References

Okunishi H, Spragg J, Burton J. In vivo assay of specific kallikrein inhibitors. Agents Actions Suppl. 1987;22:381-90. PubMed PMID: 3481213. Okunishi H, Spragg J, Burton J, Toda N. In vivo inhibition of tissue kallikreins by kininogen sequence analogue peptides. Adv Exp Med Biol. 1989;247B:23-8. PubMed PMID: 2481944. Rebuffat P, Neri G, Bah?elioglu M, Malendowicz LK, Nussdorfer GG. Prolonged kallikrein inhibition does not affect the basal growth and secretory capacity of rat adrenal cortex, but enhances mineralo- and glucocorticoid response to ACTH and handling stress. Histol Histopathol. 2000 Apr;15(2):441-4. doi: 10.14670/HH-15.441. PubMed PMID: 10809362. Burton J, Benetos A. The design of specific inhibitors of tissue kallikrein and their effect on the blood pressure of the rat. Adv Exp Med Biol. 1989;247B:9-13. PubMed PMID: 2610106.